SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)


Werte in diesem Artikel

NEW YORK, May 20, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) on behalf of the company's shareholders. The investigation seeks to determine whether ANI Pharmaceuticals's directors breached their fiduciary duties in connection with recent corporate actions.

Purcell & Lefkowitz LLP (PRNewsfoto/Purcell & Lefkowitz LLP)

If you are a shareholder of ANI Pharmaceuticals, Inc. and are interested in obtaining additional information about your rights and options, please visit us at: https://pjlfirm.com/ani-pharmaceuticals-inc/

You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000. One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit https://pjlfirm.com. Attorney advertising. Prior results do not guarantee a similar outcome.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-purcell--lefkowitz-llp-announces-shareholder-investigation-of-ani-pharmaceuticals-inc-nasdaq-anip-302150094.html

SOURCE Purcell & Lefkowitz LLP

Aktuelle Biosante Pharmaceuticals Aktie News

Werbung

Biosante Pharmaceuticals Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Biosante Pharmaceuticals nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
16.10.17 Biosante Pharmaceuticals Buy Canaccord Adams
31.07.17 Biosante Pharmaceuticals Buy Canaccord Adams
24.05.16 Biosante Pharmaceuticals Hold Standpoint Research
13.11.15 Biosante Pharmaceuticals Buy Standpoint Research
28.09.15 Biosante Pharmaceuticals Buy ROTH Capital Partners, LLC